1.1
Health Effects
Inhalation
of fungal spores, fragments (parts), or metabolites (e.g., mycotoxins
and volatile organic compounds) from a wide variety of fungi may lead
to or exacerbate immunologic (allergic) reactions, cause toxic
effects, or cause infections.11, 12, 24
There
are only a limited number of documented cases of health problems from
indoor exposure to fungi. The intensity of exposure and health effects
seen in studies of fungal exposure in the indoor environment was
typically much less severe than those that were experienced by
agricultural workers but were of a long-term duration.5-10, 12,
14, 16-20, 25-27 Illnesses can result from both high level,
short-term exposures and lower level, long-term exposures. The most
common symptoms reported from exposures in indoor environments are
runny nose, eye irritation, cough, congestion, aggravation of asthma,
headache, and fatigue.11, 12, 16-20
The
presence of fungi on building materials as identified by a visual
assessment or by bulk/surface sampling results does not necessitate
that people will be exposed or exhibit health effects. In order for
humans to be exposed indoors, fungal spores, fragments, or metabolites
must be released into the air and inhaled, physically contacted
(dermal exposure), or ingested. Whether or not symptoms develop in
people exposed to fungi depends on the nature of the fungal material
(e.g., allergenic, toxic, or infectious), the amount of exposure, and
the susceptibility of exposed persons. Susceptibility varies with the
genetic predisposition (e.g., allergic reactions do not always occur
in all individuals), age, state of health, and concurrent exposures.
For these reasons, and because measurements of exposure are not
standardized and biological markers of exposure to fungi are largely
unknown, it is not possible to determine "safe" or
"unsafe" levels of exposure for people in general.
1.1.1
Immunological Effects
Immunological
reactions include asthma, HP, and allergic rhinitis. Contact with
fungi may also lead to dermatitis. It is thought that these conditions
are caused by an immune response to fungal agents. The most common
symptoms associated with allergic reactions are runny nose, eye
irritation, cough, congestion, and aggravation of asthma.11, 12
HP may occur after repeated exposures to an allergen and can result in
permanent lung damage. HP has typically been associated with repeated
heavy exposures in agricultural settings but has also been reported in
office settings.25, 26, 27 Exposure to fungi through
renovation work may also lead to initiation or exacerbation of
allergic or respiratory symptoms.
1.1.2
Toxic Effects
A
wide variety of symptoms have been attributed to the toxic effects of
fungi. Symptoms, such as fatigue, nausea, and headaches, and
respiratory and eye irritation have been reported. Some of the
symptoms related to fungal exposure are non-specific, such as
discomfort, inability to concentrate, and fatigue.11, 12, 16-20
Severe illnesses such as ODTS and pulmonary hemosiderosis have also
been attributed to fungal exposures.5-10, 21, 22
ODTS
describes the abrupt onset of fever, flu-like symptoms, and
respiratory symptoms in the hours following a single, heavy
exposure to dust containing organic material including fungi. It
differs from HP in that it is not an immune-mediated disease and does
not require repeated exposures to the same causative agent. ODTS may
be caused by a variety of biological agents including common species
of fungi (e.g., species of Aspergillus and Penicillium).
ODTS has been documented in farm workers handling contaminated
material but is also of concern to workers performing renovation work
on building materials contaminated with fungi.5-10
Some
studies have suggested an association between SC and pulmonary
hemorrhage/hemosiderosis in infants, generally those less than six
months old. Pulmonary hemosiderosis is an uncommon condition that
results from bleeding in the lungs. The cause of this condition is
unknown, but may result from a combination of environmental
contaminants and conditions (e.g., smoking, fungal contaminants and
other bioaerosols, and water-damaged homes), and currently its
association with SC is unproven.21, 22, 23
1.1.3
Infectious Disease
Only
a small group of fungi have been associated with infectious disease.
Aspergillosis is an infectious disease that can occur in
immunosuppressed persons. Health effects in this population can be
severe. Several species of Aspergillus are known to cause
aspergillosis. The most common is Aspergillus fumigatus.
Exposure to this common mold, even to high concentrations, is unlikely
to cause infection in a healthy person.11, 24
Exposure
to fungi associated with bird and bat droppings (e.g., Histoplasma
capsulatum and Cryptococcus neoformans) can lead to
health effects, usually transient flu-like illnesses, in healthy
individuals. Severe health effects are primarily encountered in
immunocompromised persons.24, 28, 29
1.2
Medical Evaluation
Individuals
with persistent health problems that appear to be related to fungi or
other bioaerosol exposure should see their physicians for a referral
to practitioners who are trained in occupational/environmental
medicine or related specialties and are knowledgeable about these
types of exposures. Infants (less than 12 months old) who are
experiencing non-traumatic nosebleeds or are residing in dwellings
with damp or moldy conditions and are experiencing breathing
difficulties should receive a medical evaluation to screen for
alveolar hemorrhage. Following this evaluation, infants who are
suspected of having alveolar hemorrhaging should be referred to a
pediatric pulmonologist. Infants diagnosed with pulmonary
hemosiderosis and/or pulmonary hemorrhaging should not be returned to
dwellings until remediation and air testing are completed.
Clinical
tests that can determine the source, place, or time of exposure to
fungi or their products are not currently available. Antibodies
developed by exposed persons to fungal agents can only document that
exposure has occurred. Since exposure to fungi routinely occurs in
both outdoor and indoor environments this information is of limited
value.
1.3
Medical Relocation
Infants
(less than 12 months old), persons recovering from recent surgery, or
people with immune suppression, asthma, hypersensitivity pneumonitis,
severe allergies, sinusitis, or other chronic inflammatory lung
diseases may be at greater risk for developing health problems
associated with certain fungi. Such persons should be removed from the
affected area during remediation (see Section 3,